Luminex Corp LMNX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
32.23UNCH (UNCH)
Volume
4,950
Close
32.23quote price arrow up+0.09 (+0.28%)
Volume
556,454
52 week range
20.61 - 41.69

...

Loading . . .

KEY STATS

  • Open32.37
  • Day High32.91
  • Day Low31.49
  • Prev Close32.14
  • 52 Week High41.69
  • 52 Week High Date08/05/20
  • 52 Week Low20.61
  • 52 Week Low Date10/21/20
  • Market Cap1.505B
  • Shares Out46.69M
  • 10 Day Average Volume1.72M
  • Dividend0.40
  • Dividend Yield1.24%
  • Beta0.55
  • 1 Year % Change17.63

RATIOS/PROFITABILITY

  • EPS (TTM)0.32
  • P/E (TTM)99.85
  • Fwd P/E (NTM)44.83
  • EBITDA (MRQ)72.926M
  • ROE (MRQ)3.03%
  • Revenue (MRQ)417.40M
  • Gross Margin (MRQ)59.38%
  • Net Margin (MRQ)3.63%
  • Debt To Equity (MRQ)39.24%

EVENTS

  • Earnings Date05/03/2021
  • Ex Div Date03/24/2021
  • Div Amount0.10
  • Split Date-
  • Split Factor-

Latest Luminex Corp News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the...
Nachum Shamir
President
Harriss Currie CPA
Chief Financial Officer
Address
12212 Technology Blvd, 512-219-8020
Austin, TX
78727
United States